In PASMCs from PAH patients, PDE1 and PDE3 activities were higher, ranking as follows: PDE3 > PDE1 ≥ PDE4 > PDE2 [52,89,90]. This evidence concerns the gene PDE4A and pulmonary arterial hypertension.